Macquarie Maintains Outperform on Imax, Raises Price Target to $48
Benzinga Newsdesk 4 months ago
NewsPrice TargetAnalyst Ratings
Macquarie analyst Chad Beynon maintains Imax (NYSE:IMAX) with a Outperform and raises the price target from $46 to $48.
Macquarie analyst Chad Beynon maintains Imax (NYSE:IMAX) with a Outperform and raises the price target from $46 to $48.